Pasi Pengermä

Pasi Pengermä

Auto-generated profile, based on publicly available information

Pasi Pengermä

Department of Gastrointestinal Surgery, Mikkeli Central Hospital, Mikkeli, Finland; Faculty of Health Sciences, School of Medicine, Department of Clinical Medicine, University of Eastern Finland, Kuopio, Finland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2022 in The Lancet Global Health
Verified
Journal Article
Open access
CSCatherine A Shaw
Catherine A Shaw
RPRiinu Pius
Riinu Pius
TDThomas M Drake
Thomas M Drake
LNLisa Norman
Lisa Norman
AAAdesoji O Ademuyiwa
Adesoji O Ademuyiwa
JLJean Wilguens Lartigue
Jean Wilguens Lartigue
Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide. A multimethods analysis was performed as part of the GlobalSurg 3 study—a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital. Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3·85 [95% CI 2·58–5·75]; p<0·0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63·0% vs 82·7%; OR 0·35 [0·23–0·53]; p<0·0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer. Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised. National Institute for Health and Care Research.

17 June 2025 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
EBEszter Bako
Eszter Bako
PPPasi Pengermä
Pasi Pengermä
EPErik Palm
Erik Palm
PSPetri Saari
Petri Saari
SVSari Venesmaa
Sari Venesmaa
JKJussi M. Kärkkäinen
Jussi M. Kärkkäinen
To determine contemporary incidence rates of AMI and CMI. A single centre retrospective population based study. The study cohort included patients treated for AMI or CMI between 2009 and 2023 who lived in a well defined region of 250 000 inhabitants in Eastern Finland. Incidence rates with 95% confidence intervals (CIs) for arterial occlusive AMI and CMI were calculated, and stratified by age, sex, and aetiology. Age standardised incidence rates were compared between the sexes using indirect method. Venous and non-occlusive mesenteric ischaemia and median arcuate ligament syndrome were excluded. Within the study cohort, 141 patients had arterial occlusive AMI. Forty two patients (29.8%) had embolic AMI (15; 35.7% males and 27; 64.3% females) and 99 (70.2%) thrombotic AMI (50; 51% males and 49; 49% females. Fifty three patients had CMI due to atherosclerotic mesenteric artery disease (17; 32% males and 36; 68% females). The incidence rate of occlusive arterial AMI was 3.7/100 000 persons/year (95% CI 3.2 - 4.4) and 1.4/100 000 persons/year (95% CI 1.1 - 1.8) for CMI. In population aged 70 years or more, the incidence rates were 18.4/100 000 persons/year (95% CI 15.1 - 22.1) for AMI and 7.0/100 000 persons/year (95% CI 5.1 - 9.4) for CMI. The incidence rates of embolic AMI and CMI in females were nearly twice as high as in males whereas no sex related differences were observed in the incidence rates of thrombotic AMI. However, age standardised incidence rates did not differ significantly between the sexes. There were only three cases of embolic AMI, three cases of thrombotic AMI, and no cases of CMI in patients aged less than 60 years. It is important to recognise AMI as a potential cause of acute abdominal pain in elderly emergency room patients. The incidence of atherosclerotic CMI was lower than previously reported.

19 December 2025 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
EBEszter Bakó
Eszter Bakó
EPErik Palm
Erik Palm
PPPasi Pengermä
Pasi Pengermä
JKJari Karjalainen
Jari Karjalainen
JHJari Halonen
Jari Halonen
JKJussi M. Kärkkäinen
Jussi M. Kärkkäinen
To evaluate outcomes of endovascular treatment as the first line approach for acute mesenteric ischaemia (AMI) caused by embolic occlusion of the mesenteric arteries. This retrospective, single centre study included consecutive patients with occlusive AMI between 2009 and 2024. Patients with acute embolic occlusion of the mesenteric artery were included, whereas patients with thrombotic AMI were excluded. The diagnosis was confirmed by computed tomography, intra-operative findings, or autopsy. Main outcomes included rates of technical success, endovascular procedure related complications, 30 day mortality, laparotomy, and bowel resection. Of 63 patients with embolic AMI (mean age 79 ± 12 years), 15 were treated without attempted revascularisation, of whom three survived. Forty eight patients (76%, mean age 79 ± 11 years) underwent endovascular revascularisation as the first line treatment, with technical success in 47 (98%). Mechanical aspiration was performed in 45 patients, with additional balloon angioplasty in four, stenting in nine, thrombolysis in three, and stent retriever thrombectomy in three. Plain stent placement without aspiration was performed in three patients. Laparotomy was performed in 15 patients (35%) undergoing endovascular treatment; six had clinical signs of peritonitis (13%) and nine (21%) required bowel resection. Seven patients (15%) had endovascular procedure related complications (superior mesenteric artery dissection in five, access site bleeding in one, and access site pseudoaneurysm in another patient). Of the 48 patients treated with endovascular revascularisation, 21 (44%) died within 30 days. Factors prominently associated with early death after endovascular revascularisation in univariable analysis were older age (p = .001), clinical signs of peritonitis (p = .003), decreased bowel wall enhancement (p = .004), increased lactate level (p = .006), low bicarbonate level (p = .008), and low base excess (p = .009). An endovascular first approach was suitable for most patients, with a good technical success rate and acceptable mortality rate considering the high mean age of the non-selected patients with AMI. One third underwent laparotomy after endovascular treatment, whereas all patients would have required laparotomy if treated with open embolectomy.

25 June 2021 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
PPPasi Pengermä
Pasi Pengermä
JKJevgeni Katunin
Jevgeni Katunin
ATArto Turunen
Arto Turunen
IRIoannis Rouvelas
Ioannis Rouvelas
APAri Palomäki
Ari Palomäki
AMAri Palomäki Md
Ari Palomäki Md

16 January 2026 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
PPPasi Pengermä
Pasi Pengermä
JKJussi M. Kärkkäinen
Jussi M. Kärkkäinen

2 September 2025 in Journal of Vascular Surgery
Verified
Journal Article
Open access
PPPasi Pengermä
Pasi Pengermä
EPErik Palm
Erik Palm
EBEszter Bako
Eszter Bako
SVSari Venesmaa
Sari Venesmaa
JKJari Karjalainen
Jari Karjalainen
JKJussi M. Kärkkäinen
Jussi M. Kärkkäinen
To investigate the prevalence of mesenteric artery stenosis and its association with acute mesenteric ischemia (AMI) among elderly patients presenting to the emergency department with acute abdominal pain. This single-center retrospective cohort study included 500 consecutive patients aged ≥65 years who underwent contrast-enhanced computed tomography in the emergency department owing to acute abdominal pain between 2013 and 2014. Imaging data were retrospectively evaluated by a consultant interventional radiologist for 50% or greater stenosis of the superior mesenteric artery (SMA), celiac artery (CA), and inferior mesenteric artery (IMA). The main outcomes of interest were the prevalence of atherosclerotic mesenteric artery stenosis in patients with acute abdominal pain, the prevalence of AMI in patients with mesenteric artery stenosis, and later presentation of mesenteric ischemia until the end of the follow-up, August 2025. Altogether, 123 patients (25%) had a mesenteric artery stenosis. Fifty-nine patients (12%) had ≥50% stenosis of the SMA, of whom 28 (5.6%) had 50% to 69% SMA stenosis and 31 (6.2%) had ≥70% SMA stenosis or total occlusion. In patients with SMA stenosis, a concomitant CA stenosis was recorded in 22 patients (37%) and 11 (19%) had a three-vessel disease involving the SMA, CA, and IMA. Forty patients (8.0%) had multivessel stenosis (SMA + CA, SMA + IMA, CA + IMA or SMA + CA + IMA). The prevalence of SMA stenosis increased with age; it was observed in 22 (6.9%) patients aged 65 to 79 years and in 37 (20%) patients aged ≥80 years. There were 14 patients (2.8%) with isolated 50% to 69% stenosis of the SMA of whom none had AMI at presentation; 9 patients (1.8%) had isolated ≥70% SMA stenosis of whom 2 (22%) presented with AMI. Of all patients with ≥70% SMA stenosis, 12 of 31 (39%) presented with AMI, and 12 of 40 (30%) with any multivessel stenosis presented with AMI. One of the patients with incidental mesenteric artery stenosis (ie, no AMI at presentation) developed symptomatic mesenteric ischemia during follow-up. Mesenteric artery stenosis is a relatively common clinical problem in elderly patients with acute abdomen. The risk of AMI is significant in emergency room patients with ≥70% SMA stenosis and involvement of other mesenteric arteries (multivessel disease). Occurrence of later symptoms seems to be rare in patients with incidental asymptomatic mesenteric artery stenosis.